Circassia Pharmaceuticals's market cap is currently £364.47M. The company's EPS TTM is $0.01887683; its P/E ratio is 53.50; and it has a dividend yield of 1.81%. Circassia Pharmaceuticals is scheduled to report earnings on September 30, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 19
Dec 18
Dec 17
Dec 16
Currency in GBP
Circassia Pharmaceuticals Earnings and Revenue History
